Literature DB >> 12942245

Health risks for early (< or =19) and late (> or =35) childbearing.

Sinan Ozalp1, H Mete Tanir, Turgay Sener, Sibel Yazan, Ali E Keskin.   

Abstract

Both adolescents and women of advanced reproductive age comprise distinct groups of obstetrics patients. Each has special needs and is susceptible to different obstetric risks. Pregnant teenagers appear to be at increased risk for poor maternal weight gain, abortions, hypertensive disorders and delivery of low birthweight infants. Pregnant women over the age of 34 have an increased risk for a poor obstetric outcome as a result of an increased risk for chromosomal aneuploidies and their higher likelihood of having a chronic disease, such as chronic hypertension or diabetes mellitus, to complicate their pregnancies. This study emphasises the increased maternal and fetal risks for pregnancies at these extreme age groups in a retrospective way. Prepregnancy counselling is essential for these age groups in order for a woman to be able to make an informed decision regarding the timing of childbearing.

Entities:  

Mesh:

Year:  2002        PMID: 12942245     DOI: 10.1007/s00404-002-0359-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  Obstetric outcomes of elderly primiparous singleton pregnancies conceived by in vitro fertilization compared with those conceived spontaneously.

Authors:  Shunji Suzuki; Hidehiko Miyake
Journal:  Reprod Med Biol       Date:  2007-11-07

2.  Preterm delivery and low birth weight in singleton pregnancies conceived by women with and without a history of infertility.

Authors:  Loretta Camarano; Abbey Alkon; Robert D Nachtigall; Michael Schembri; Sandra Weiss; Mary S Croughan
Journal:  Fertil Steril       Date:  2012-05-24       Impact factor: 7.329

3.  Economic recession and first births in Europe: recession-induced postponement and recuperation of fertility in 14 European countries between 1970 and 2005.

Authors:  Karel Neels; Zita Theunynck; Jonas Wood
Journal:  Int J Public Health       Date:  2012-07-26       Impact factor: 3.380

4.  The Long-Term Consequences of Childbearing: Physical and Psychological Well-Being of Mothers in Later Life.

Authors:  Naomi J Spence
Journal:  Res Aging       Date:  2008

5.  Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008.

Authors:  Reeta Lamminpää; Katri Vehviläinen-Julkunen; Mika Gissler; Seppo Heinonen
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-11       Impact factor: 3.007

6.  Improved Assay for Quantifying a Redox Form of Angiotensinogen as a Biomarker for Pre-Eclampsia: A Case-Control Study.

Authors:  Soheila Rahgozar; Tayebeh Amirian; Miao Qi; Zahra Shahshahan; Mansureh Entezar-E-Ghaem; Hatav Ghasemi Tehrani; Mehran Miroliaei; Steven A Krilis; Bill Giannakopoulos
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

7.  Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience.

Authors:  Georgeanna J Klingensmith; Laura Pyle; Kristen J Nadeau; Linda A Barbour; Robin S Goland; Steven M Willi; Barbara Linder; Neil H White
Journal:  Diabetes Care       Date:  2015-12-01       Impact factor: 19.112

8.  Neither early nor late for becoming pregnant: Comparison of the perinatal outcomes of adolescent, reproductive age, and advanced maternal age pregnancies.

Authors:  Orkun Çetin; Fatma Ferda Verit; Ali Galip Zebitay; Zuhal Aydın; Zehra Kurdoğlu; Oğuz Yücel
Journal:  Turk J Obstet Gynecol       Date:  2015-09-15

9.  A review of pregnancy in women over 35 years of age.

Authors:  Reeta Lampinen; Katri Vehviläinen-Julkunen; Päivi Kankkunen
Journal:  Open Nurs J       Date:  2009-08-06

10.  Age, mode of conception, health service use and pregnancy health: a prospective cohort study of Australian women.

Authors:  Jane Fisher; Karen Wynter; Karin Hammarberg; John McBain; Frances Gibson; Jacky Boivin; Catherine McMahon
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-08       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.